Related topics

Intercept: 3Q Earnings Snapshot

November 5, 2019

NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Tuesday reported a loss of $84.8 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of $2.59.

The results fell short of Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $2.35 per share.

The drugmaker posted revenue of $62 million in the period, which also did not meet Street forecasts. Eight analysts surveyed by Zacks expected $63.4 million.

Intercept shares have declined 25% since the beginning of the year. The stock has fallen 31% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICPT at https://www.zacks.com/ap/ICPT